🚨 *JUST IN: 🇺🇸 Publicly traded MEI Pharma launches 100 million Litecoin (LTC) treasury strategy* 💼💰⚡

This is a *major milestone* for Litecoin and for crypto adoption by traditional finance.

🧠 What it means:

- *MEI Pharma*, a Nasdaq-listed company, is allocating 100M of its treasury into *Litecoin*, signaling growing trust in LTC as a long-term store of value.

- Similar to how Tesla and MicroStrategy embraced Bitcoin, MEI is betting on *Litecoin’s resilience, speed, and low fees* to preserve and grow their capital.

📊 Why Litecoin?

- ✅ One of the oldest, most secure proof-of-work blockchains

- 💸 Fast transaction speeds + low fees = solid for payments

- 🪙 Capped supply of 84 million — similar to Bitcoin in structure

- 🏛️ Now gaining *institutional exposure*, which was rare until now

🔮 Predictions Market Outlook:

- This move could spark a *new wave of corporate treasury investments* into Litecoin, especially from mid-cap firms looking for Bitcoin alternatives.

- Expect *short-term price momentum* and *renewed media attention* on LTC.

- Could trigger *increased LTC liquidity* on major platforms and *more integration in fintech/payment apps*.

📈 Potential Targets (if momentum continues):

- *TP1:*112

- *TP2:* 128

- *TP3:*145

- *SL:* $95 (tight invalidation zone)

📢 This kind of *mainstream validation* may mark the start of a *Litecoin renaissance*. Keep your eyes on LTC in this cycle. 🧠🚀🪙

$LTC

$ENA

#BinanceHODLerC #AltcoinBreakout #ETHBreakout3.5k #BinanceHODLerERA